Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Global - API Market (Billion US$), 2012-2017
Figure 4-2: Global - Share of Captive and Merchant Market in API Market (2012)
Figure 4-3: Global - API Captive Market (Billion US$), 2012-2017
Figure 4-4: Global - API Merchant Market (Billion US$), 2012-2017
Figure 4-5: Global - Share of Branded and Generic APIs in API Merchant Market (2012)
Figure 4-6: Global - Generic API Merchant Market (Billion US$), 2012-2017
Figure 4-7: Global - Branded API Merchant Market (Billion US$), 2012-2017
Figure 4-8: Global - Share of Synthetic and Biotech APIs in API Market (2012)
Figure 5-1: Global - Price Structure for Pharmaceutical Fine Chemicals in US, India and China (%)
Figure 7-1: China - Pharmaceutical Industry by Segment (2010)
Figure 7-2: China - API Merchant Market (Billion US$), 2012-2017
Figure 7-3: China - Share in Global API Merchant Market (2012)
Figure 7-4: China - Generic API Merchant Market (Billion US$), 2012-2017
Figure 7-5: China - Share in Global Generic API Merchant Market (2012)
Figure 7-6: India - API Merchant Market (Billion US$), 2012-2017
Figure 7-7: India - Share in Global API Merchant Market (2012)
Figure 7-8: India - Generic API Merchant Market (Billion US$), 2012-2017
Figure 7-9: India - Share in Global Generic API Merchant Market (2012)
Figure 7-10: Italy - API Merchant Market (Billion US$), 2012-2017
Figure 7-11: Italy - Share in Global API Merchant Market (2012)
Figure 7-12: Italy - Number of API Producers and Manufacturing Plants (1991, 2000 & 2009)
Figure 7-13: Italy - Generic API Merchant Market (Billion US$), 2012-2017
Figure 7-14: Italy - Share in Global Generic API Merchant Market (2012)
Figure 7-15: Taiwan - API Market (Billion NT$), 2010 & 2011
Figure 8-1: Global - HPAPI Market (Billion US$), 2012-2017
Figure 8-2: Global - Share of Synthetic and Biotech HPAPIs in HPAPI Market (2012)
Figure 8-3: Global - Share of Generics and Branded in HPAPI Market (2012)

List of Tables:

Table 3-1: Classification of Bulk Drugs
Table 5-1: Global - Fine Chemical Industry Labor Cost and Productivity in Key Regions (2010)
Table 5-2: Global - Investment Cost Comparison for Multi-Purpose Pharmaceutical Fine Chemical Plants in Key Countries
Table 7-1: China - Number of API Companies by Province
Table 7-2: India - Number of Bulk Drugs Manufacturing Units
Table 7-3: Taiwan - Number of Pharmaceutical Licenses by Type (2010)
Table 9-1: Scope of Authority for Regulatory Agencies
Table 10-1: Dr. Reddy's Laboratories - Strengths and Weaknesses
Table 10-2: Cipla - Strengths and Weaknesses
Table 10-3: Ranbaxy Laboratories - Strengths and Weaknesses
Table 10-4: Zhejiang Hisun Pharmaceutical - Strengths and Weaknesses
Table 10-5: Fabbrica Italiana Sintetici - Strengths and Weaknesses
Table 10-6: Cambrex Corporation - Strengths and Weaknesses
Table 10-7: Pfizer CentreSource - Strengths and Weaknesses
Table 10-8: Teva Active Pharmaceutical Ingredients - Strengths and Weaknesses
Table 10-9: Lonza - Strengths and Weaknesses
Table 10-10: Daiichi Fine Chemical - Strengths and Weaknesses
Table 10-11: Boehringer Ingelheim - Strengths and Weaknesses
Table 10-12: BASF - Strengths and Weaknesses
Table 10-13: Royal DSM - Strengths and Weaknesses
Table 10-14: Divis Laboratories Limited - Strengths and Weaknesses
Table 10-15: Aurobindo Pharma Limited - Strengths and Weaknesses